naproxen sodium 220 MG Oral Capsule [Aleve]
- RxCUI
- 1112233
- RxNorm name
- naproxen sodium 220 MG Oral Capsule [Aleve]
- Display name
- ALEVE (Oral Pill)
- Full name
- naproxen sodium 220 MG Oral Capsule [Aleve]
- Term type
- SBD
- Status
- Active
- Strength
- 220 mg
- Dose form
- Cap
- Route
- Oral Pill
- Updated
- 2026-10-15 15:42:42
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 072011
- Active start
- 072011
- Multiple ingredient
- NO
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| naproxen sodium | 220 MG / 1 EACH | naproxen | naproxen sodium |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Oral Capsule | 316965 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| naproxen | 7258 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | Aleve 220 MG Oral Capsule | 1 | NAMES |
| RxNorm Name | naproxen sodium 220 MG Oral Capsule [Aleve] | 1 | NAMES |
| RxNorm Synonym | 2 | NAMES | |
| TTY | SBD | 1 | ATTRIBUTES |
| SPL_SET_ID | 3 | CODES | |
| RxCUI | 1112233 | 1 | CODES |
| MMSL_CODE | BD27199 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 0280-0105-01 | 0280-0105 | Aleve liquid gels Naproxen Sodium | Bayer Healthcare LLC | ANDA214463 |
| 0280-0105-02 | 0280-0105 | Aleve liquid gels Naproxen Sodium | Bayer Healthcare LLC | ANDA214463 |
| 0280-0105-03 | 0280-0105 | Aleve liquid gels Naproxen Sodium | Bayer Healthcare LLC | ANDA214463 |
| 0280-0105-04 | 0280-0105 | Aleve liquid gels Naproxen Sodium | Bayer Healthcare LLC | ANDA214463 |
| 0280-0105-05 | 0280-0105 | Aleve liquid gels Naproxen Sodium | Bayer Healthcare LLC | ANDA214463 |
| 0280-0105-06 | 0280-0105 | Aleve liquid gels Naproxen Sodium | Bayer Healthcare LLC | ANDA214463 |
| 0280-6080-01 | 0280-6080 | Aleve Naproxen Sodium | Bayer HealthCare LLC. | NDA021920 |
| 0280-6080-02 | 0280-6080 | Aleve Naproxen Sodium | Bayer HealthCare LLC. | NDA021920 |
| 0280-6080-04 | 0280-6080 | Aleve Naproxen Sodium | Bayer HealthCare LLC. | NDA021920 |
| 0280-6080-16 | 0280-6080 | Aleve Naproxen Sodium | Bayer HealthCare LLC. | NDA021920 |
| 0280-6080-20 | 0280-6080 | Aleve Naproxen Sodium | Bayer HealthCare LLC. | NDA021920 |
| 0280-6080-40 | 0280-6080 | Aleve Naproxen Sodium | Bayer HealthCare LLC. | NDA021920 |
| 0280-6080-80 | 0280-6080 | Aleve Naproxen Sodium | Bayer HealthCare LLC. | NDA021920 |
| 0280-6091-80 | 0280-6091 | Aleve Naproxen Sodium | Bayer HealthCare LLC. | NDA021920 |
Drugs@FDA Applications#
| Application | NDC | Name | Marketing category | Labeler |
|---|---|---|---|---|
| ANDA214463 | 0280-0105 | Aleve liquid gels Naproxen Sodium | ANDA | Bayer Healthcare LLC |
| NDA021920 | 0280-6080 | Aleve Naproxen Sodium | NDA | Bayer HealthCare LLC. |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Aleve | NAPROXEN SODIUM | Bayer HealthCare LLC. | 1266393e-b55e-4e34-9710-0b87209f4158 | 2025-12-04 | Warnings | 0280-6080-01 0280-6080-04 0280-6080-40 0280-6080-80 0280-6080-16 0280-6080-20 0280-6080-02 0280-6080 00280608004 00280608003 00280608001 00280608016 00280608020 00280608080 00280608002 00280608040 1112233 |
| Aleve Easy Open Arthritis Cap | NAPROXEN SODIUM | Bayer HealthCare LLC. | 3b5442c6-c6e1-4df3-8cec-40bbb4ec469f | 2025-12-04 | Warnings | 0280-6091-80 0280-6091 00280609180 1112233 |
| Aleve liquid gels | NAPROXEN SODIUM | Bayer Healthcare LLC | a0587c73-d297-462d-a0ef-750cb324486e | 2024-05-06 | Warnings | 0280-0105-06 0280-0105-01 0280-0105-04 0280-0105-03 0280-0105-05 0280-0105-02 0280-0105 00280010505 00280010503 00280010502 00280010504 00280010506 00280010501 1112233 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 1266393e-b55e-4e34-9710-0b87209f4158 | Aleve 220 MG Oral Capsule [PSN] · naproxen sodium 220 MG Oral Capsule [Aleve] [SBD] · Aleve 220 MG (naproxen 200 MG) Oral Capsule [SY] · Aleve 220 MG Oral Capsule [SY] | 4 | 16 | ALEVE ® LIQUID GELS | 20251204 |
| 3b5442c6-c6e1-4df3-8cec-40bbb4ec469f | Aleve 220 MG Oral Capsule [PSN] · naproxen sodium 220 MG Oral Capsule [Aleve] [SBD] · Aleve 220 MG (naproxen 200 MG) Oral Capsule [SY] · Aleve 220 MG Oral Capsule [SY] | 4 | 11 | ALEVE ® LIQUID GELS | 20251204 |
| a0587c73-d297-462d-a0ef-750cb324486e | Aleve 220 MG Oral Capsule [PSN] · naproxen sodium 220 MG Oral Capsule [Aleve] [SBD] · Aleve 220 MG (naproxen 200 MG) Oral Capsule [SY] · Aleve 220 MG Oral Capsule [SY] | 4 | 2 | ALEVE LIQUID GELS | 20240506 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 1266393e-b55e-4e34-9710-0b87209f4158 | ALEVE ® LIQUID GELS | Bayer HealthCare LLC. | 20251204 |
| 3b5442c6-c6e1-4df3-8cec-40bbb4ec469f | ALEVE ® LIQUID GELS | Bayer HealthCare LLC. | 20251204 |
| a0587c73-d297-462d-a0ef-750cb324486e | ALEVE LIQUID GELS | Bayer Healthcare LLC | Patheon Softgels Inc. | 20240506 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | M02AA | Antiinflammatory preparations, non-steroids for topical use | ATC1-4 | naproxen | |
| ATC | G02CC | Antiinflammatory products for vaginal administration | ATC1-4 | naproxen | |
| ATC | M01AE | Propionic acid derivatives | ATC1-4 | naproxen | |
| FDASPL | N0000175722 | Nonsteroidal Anti-inflammatory Drug | EPC | has_epc | naproxen |
| FDASPL | N0000000160 | Cyclooxygenase Inhibitors | MOA | has_moa | naproxen |
| MEDRT | D009288 | Naproxen | CHEM | has_ingredient | naproxen |
| MEDRT | D009288 | Naproxen | CHEM | has_ingredient | naproxen sodium |
| MEDRT | D001171 | Arthritis, Juvenile | DISEASE | may_treat | naproxen sodium |
| MEDRT | D001171 | Arthritis, Juvenile | DISEASE | may_treat | naproxen |
| MEDRT | D001172 | Arthritis, Rheumatoid | DISEASE | may_treat | naproxen sodium |
| MEDRT | D001172 | Arthritis, Rheumatoid | DISEASE | may_treat | naproxen |
| MEDRT | D001416 | Back Pain | DISEASE | may_treat | naproxen sodium |
| MEDRT | D001416 | Back Pain | DISEASE | may_treat | naproxen |
| MEDRT | D002062 | Bursitis | DISEASE | may_treat | naproxen sodium |
| MEDRT | D002062 | Bursitis | DISEASE | may_treat | naproxen |
| MEDRT | D003139 | Common Cold | DISEASE | may_treat | naproxen sodium |
| MEDRT | D003139 | Common Cold | DISEASE | may_treat | naproxen |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | naproxen sodium |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | naproxen |
| MEDRT | D004412 | Dysmenorrhea | DISEASE | may_treat | naproxen sodium |
| MEDRT | D004412 | Dysmenorrhea | DISEASE | may_treat | naproxen |
| MEDRT | D005334 | Fever | DISEASE | may_treat | naproxen sodium |
| MEDRT | D005334 | Fever | DISEASE | may_treat | naproxen |
| MEDRT | D006073 | Gout | DISEASE | may_treat | naproxen |
| MEDRT | D006073 | Gout | DISEASE | may_treat | naproxen sodium |
| MEDRT | D006261 | Headache | DISEASE | may_treat | naproxen sodium |
| MEDRT | D006261 | Headache | DISEASE | may_treat | naproxen |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | naproxen |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | naproxen sodium |
| MEDRT | D010003 | Osteoarthritis | DISEASE | may_treat | naproxen sodium |
| MEDRT | D010003 | Osteoarthritis | DISEASE | may_treat | naproxen |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | naproxen |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | naproxen sodium |
| MEDRT | D011263 | Pregnancy Trimester, Third | DISEASE | ci_with | naproxen |
| MEDRT | D011263 | Pregnancy Trimester, Third | DISEASE | ci_with | naproxen sodium |
| MEDRT | D013167 | Spondylitis, Ankylosing | DISEASE | may_treat | naproxen |
| MEDRT | D013167 | Spondylitis, Ankylosing | DISEASE | may_treat | naproxen sodium |
| MEDRT | D014098 | Toothache | DISEASE | may_treat | naproxen |
| MEDRT | D014098 | Toothache | DISEASE | may_treat | naproxen sodium |
| MEDRT | N0000000160 | Cyclooxygenase Inhibitors | MOA | has_moa | naproxen sodium |
| MEDRT | N0000000160 | Cyclooxygenase Inhibitors | MOA | has_moa | naproxen |
| MEDRT | N0000008831 | Decreased Platelet Activating Factor Production | PE | has_pe | naproxen sodium |
| MEDRT | N0000008831 | Decreased Platelet Activating Factor Production | PE | has_pe | naproxen |
| MEDRT | N0000008836 | Decreased Prostaglandin Production | PE | has_pe | naproxen sodium |
| MEDRT | N0000008836 | Decreased Prostaglandin Production | PE | has_pe | naproxen |
| MEDRT | N0000009006 | Decreased Thromboxane Production | PE | has_pe | naproxen |
| MEDRT | N0000009006 | Decreased Thromboxane Production | PE | has_pe | naproxen sodium |
| MEDRT | N0000000042 | Renal Excretion | PK | has_pk | naproxen |
| MEDRT | N0000000042 | Renal Excretion | PK | has_pk | naproxen sodium |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 220 MG |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | ANDA | ANDA214463 |
| CODES | NDA | NDA021920 |
| NAMES | Prescribable Synonym | Aleve 220 MG Oral Capsule |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |